Real-World Effectiveness and Tolerability of Monoclonal Antibodies for Ambulatory Patients with Early COVID-19
View ORCID ProfileBrandon J. Webb, View ORCID ProfileWhitney Buckel, View ORCID ProfileTodd Vento, Allison M. Butler, Nancy Grisel, View ORCID ProfileSamuel M. Brown, View ORCID ProfileIthan D. Peltan, Emily S. Spivak, Mark Shah, Theadora Sakata, Anthony Wallin, View ORCID ProfileEddie Stenehjem, Greg Poulsen, View ORCID ProfileJoseph Bledsoe
doi: https://doi.org/10.1101/2021.03.15.21253646
Brandon J. Webb
1Intermountain Healthcare, Division of Infectious Diseases and Clinical Epidemiology, Salt Lake City, UT
2Stanford Medicine, Division of Infectious Diseases and Geographic Medicine, Palo Alto, CA
MDWhitney Buckel
3Intermountain Healthcare, Pharmacy Services
Todd Vento
1Intermountain Healthcare, Division of Infectious Diseases and Clinical Epidemiology, Salt Lake City, UT
Allison M. Butler
4Intermountain Healthcare, Enterprise Analytics, Salt Lake City, UT
Nancy Grisel
4Intermountain Healthcare, Enterprise Analytics, Salt Lake City, UT
Samuel M. Brown
5Intermountain Medical Center and University of Utah, Division of Pulmonary and Critical Care Medicine, Salt Lake City, UT
MDIthan D. Peltan
5Intermountain Medical Center and University of Utah, Division of Pulmonary and Critical Care Medicine, Salt Lake City, UT
MDEmily S. Spivak
6University of Utah School of Medicine, Division of Infectious Diseases, Salt Lake City, UT
MD, MHSMark Shah
7Intermountain Healthcare, Department of Emergency Medicine, Salt Lake City, UT
MDTheadora Sakata
8Intermountain Healthcare, Urgent Care Service Line, Salt Lake City, UT
MDAnthony Wallin
8Intermountain Healthcare, Urgent Care Service Line, Salt Lake City, UT
MDEddie Stenehjem
1Intermountain Healthcare, Division of Infectious Diseases and Clinical Epidemiology, Salt Lake City, UT
2Stanford Medicine, Division of Infectious Diseases and Geographic Medicine, Palo Alto, CA
9Intermountain Healthcare, Office of Patient Experience, Salt Lake City, UT
MDGreg Poulsen
10Intermountain Healthcare, Executive Leadership Team, Salt Lake City, UT
MBAJoseph Bledsoe
7Intermountain Healthcare, Department of Emergency Medicine, Salt Lake City, UT
11Stanford Medicine, Department of Emergency Medicine, Palo Alto, CA
MDArticle usage
Posted March 17, 2021.
Real-World Effectiveness and Tolerability of Monoclonal Antibodies for Ambulatory Patients with Early COVID-19
Brandon J. Webb, Whitney Buckel, Todd Vento, Allison M. Butler, Nancy Grisel, Samuel M. Brown, Ithan D. Peltan, Emily S. Spivak, Mark Shah, Theadora Sakata, Anthony Wallin, Eddie Stenehjem, Greg Poulsen, Joseph Bledsoe
medRxiv 2021.03.15.21253646; doi: https://doi.org/10.1101/2021.03.15.21253646
Real-World Effectiveness and Tolerability of Monoclonal Antibodies for Ambulatory Patients with Early COVID-19
Brandon J. Webb, Whitney Buckel, Todd Vento, Allison M. Butler, Nancy Grisel, Samuel M. Brown, Ithan D. Peltan, Emily S. Spivak, Mark Shah, Theadora Sakata, Anthony Wallin, Eddie Stenehjem, Greg Poulsen, Joseph Bledsoe
medRxiv 2021.03.15.21253646; doi: https://doi.org/10.1101/2021.03.15.21253646
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2778)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12427)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4295)
- Geriatric Medicine (397)
- Health Economics (704)
- Health Informatics (2774)
- Health Policy (1028)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (405)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4069)
- Nursing (218)
- Nutrition (603)
- Oncology (2148)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (78)
- Pathology (480)
- Pediatrics (1151)
- Primary Care Research (472)
- Public and Global Health (6675)
- Radiology and Imaging (1457)
- Respiratory Medicine (888)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)